Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance No. 67): a systematic review and economic evaluation

Citation

(2009), "Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance No. 67): a systematic review and economic evaluation", Clinical Governance: An International Journal, Vol. 14 No. 4. https://doi.org/10.1108/cgij.2009.24814dae.002

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance No. 67): a systematic review and economic evaluation

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance No. 67): a systematic review and economic evaluation

Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 14, Issue 4

P. Tappenden, R. Jackson, K. Cooper, A. Rees, E. Simpson, R. Read and K. Nicholson,Health Technology Assessment,2009,Vol. 13 No. 11,pp. 1-268

This review concluded that amantadine, oseltamivir or zanamivir showed some efficacy for seasonal and post-exposure prophylaxis. The results of the review were limited by a paucity of good quality evidence. There was a possibility of error and bias in the review process, but the overall conclusion was likely to be reliable.